London
· Delayed Price · Currency is GBP · Price in USD Madrigal Pharmaceuticals Statistics
Total Valuation
LON:0JXI has a market cap or net worth of GBP 5.57 billion. The enterprise value is 4.95 billion.
| Market Cap | 5.57B |
| Enterprise Value | 4.95B |
Important Dates
The last earnings date was Tuesday, February 25, 2025.
| Earnings Date | Feb 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +13.83% |
| Shares Change (QoQ) | +0.84% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 11.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 9.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.30 |
| EV / Sales | 35.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -13.55 |
Financial Position
The company has a current ratio of 6.10, with a Debt / Equity ratio of 0.16.
| Current Ratio | 6.10 |
| Quick Ratio | 5.79 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.26 |
| Interest Coverage | -33.94 |
Financial Efficiency
Return on equity (ROE) is -80.35% and return on invested capital (ROIC) is -44.57%.
| Return on Equity (ROE) | -80.35% |
| Return on Assets (ROA) | -36.98% |
| Return on Invested Capital (ROIC) | -44.57% |
| Return on Capital Employed (ROCE) | -57.03% |
| Revenue Per Employee | 272,509 |
| Profits Per Employee | -704,812 |
| Employee Count | 528 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.50% in the last 52 weeks. The beta is -0.76, so LON:0JXI's price volatility has been lower than the market average.
| Beta (5Y) | -0.76 |
| 52-Week Price Change | +19.50% |
| 50-Day Moving Average | 324.72 |
| 200-Day Moving Average | 280.41 |
| Relative Strength Index (RSI) | 47.88 |
| Average Volume (20 Days) | 126 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 8.96 |
Income Statement
In the last 12 months, LON:0JXI had revenue of GBP 143.88 million and -372.14 million in losses. Loss per share was -17.49.
| Revenue | 143.88M |
| Gross Profit | 138.91M |
| Operating Income | -397.69M |
| Pretax Income | -372.14M |
| Net Income | -372.14M |
| EBITDA | -396.81M |
| EBIT | -397.69M |
| Loss Per Share | -17.49 |
Balance Sheet
The company has 739.86 million in cash and 95.51 million in debt, giving a net cash position of 644.35 million.
| Cash & Cash Equivalents | 739.86M |
| Total Debt | 95.51M |
| Net Cash | 644.35M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 602.58M |
| Book Value Per Share | 27.38 |
| Working Capital | 689.86M |
Cash Flow
In the last 12 months, operating cash flow was -363.90 million and capital expenditures -1.17 million, giving a free cash flow of -365.07 million.
| Operating Cash Flow | -363.90M |
| Capital Expenditures | -1.17M |
| Free Cash Flow | -365.07M |
| FCF Per Share | n/a |
Margins
Gross margin is 96.54%, with operating and profit margins of -276.39% and -258.64%.
| Gross Margin | 96.54% |
| Operating Margin | -276.39% |
| Pretax Margin | -258.64% |
| Profit Margin | -258.64% |
| EBITDA Margin | -275.78% |
| EBIT Margin | -276.39% |
| FCF Margin | n/a |
Dividends & Yields
LON:0JXI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.83% |
| Shareholder Yield | -13.83% |
| Earnings Yield | -6.68% |
| FCF Yield | -6.55% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LON:0JXI has an Altman Z-Score of 8.33.
| Altman Z-Score | 8.33 |
| Piotroski F-Score | n/a |